InvestorsHub Logo

tredenwater2

01/06/23 9:18 PM

#396442 RE: Mikesc #396376

This also notifies BP that the approval bar for AD is set very low.... Anavex's value to BP has increase tremendously.



I agree so does that mean Lilly is next? Get too many powerhouses in the pool and it muddies the water and causes big wakes!

Superior 50 mg results coupled with PDD and OLE from both PDD and AD may be too much to pass on by the FDA.

Also I say screw the Rett Syndrome pediatric voucher at this point, ITS frickin GO TIME!!!